Daily non-political popular news in brief.

Study questions risks of anti-bleeding drug during heart surgery

Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of the Journal of Thoracic and Cardiovascular Surgery.

Read more »

Keywords: study, questions, risks, anti-bleeding, drug, heart, surgery, question, risk, anti, bleeding

« Previous | Next »

Similar news on "Study questions risks of anti-bleeding drug during heart surgery":

1. Fatal Flaw? Antibleeding drug faces new safety questions
   02-10-2007 · Science News Online
   The drug commonly used to slow bleeding during heart surgery increases a patient's risk of dying during the next 5 years.
   Similar news · Read more »
   
2. Drug interactions with warfarin
   08-13-2007 · EurekAlert!
   This real-world study of prescription data from general practices observed much higher rates of bleeding than those derived from a meta-analysis of randomized clinical trials. The authors write that physicians should be aware of these risks to better assess their patients' therapeutic risk-benefit profiles.
   Similar news · Read more »
   
3. Questions over drugs to prevent heart complications during surgery
   06-22-2007 · EurekAlert!
   The use of drugs to prevent heart complications during surgery is called into question in this week's BMJ. Globally, about 100 million adults have non-cardiac surgery (ie. on any part of the body other than the heart) each year. Around one percent are at risk of cardiac complications, such as heart attacks and strokes, and about one in four will die each year.
   Similar news · Read more »
   
4. New study questions the validity of publishing hospital mortality rates
   09-24-2007 · EurekAlert!
   A previous study of mortality rates for congenital heart surgery used routinely available hospital data that were misleading, according to a report published today on bmj.com which questions the validity of such data being made public.
   Similar news · Read more »
   
5. High-dose anticlotting drug cuts heart attack, death risk in half
   05-11-2007 · EurekAlert!
   Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
   Similar news · Read more »
   
6. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
   09-10-2007 · EurekAlert!
   In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide?
   Similar news · Read more »
   
7. Mayo Clinic study finds FDA warning against antinausea drug droperidol unnecessary
   09-28-2007 · EurekAlert!
   A Mayo Clinic review of patients' responses to a drug used to control nausea and vomiting during anesthesia for general surgery questions a US Food and Drug Administration warning against the drug's use.
   Similar news · Read more »
   
8. Blood transfusions raise heart patients' infection and death risk -- especially women
   12-19-2006 · EurekAlert!
   Blood transfusions save the lives of millions of heart surgery patients and others each year. But a new study suggests that patients who receive transfusions during heart bypass surgery have a higher risk of developing potentially dangerous infections, and dying, after their operation.
   Similar news · Read more »
   
9. Regular, long-term aspirin use reduces risk of colorectal cancer
   01-22-2008 · EurekAlert!
   The use of regular, long-term aspirin and non-steroidal anti-inflammatory drugs reduces the risk associated with colorectal cancer, according to a study published in Gastroenterology, the official journal of the American Gastroenterological Association Institute. However, the use of aspirin for chemoprevention of colorectal cancer may require using the drug at doses that are higher than recommended over a long period of time, which may cause serious side effects including gastrointestinal bleeding.
   Similar news · Read more »
   
10. Drug-eluting and bare-metal stents equal in risk of blood clots, heart attacks and death
    03-24-2007 · EurekAlert!
    Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit compared rates of complications in thousands of patients who received bare-metal stents (BMS) or DES.
    Similar news · Read more »